Introduction
Angiotensin II is an important peptide hormone regulating vascular tone and blood pressure. The vasopressor actions of angiotensin II are mediated mainly by the AT 1 receptor. In contrast, bradykinin is a vasodepressor peptide, which exerts major effects via the B 2 bradykinin receptor. The angiotensin II and bradykinin systems are intertwined at multiple levels. The angiotensin-converting enzyme (ACE) regulates the availability of both peptides in vivo by releasing angiotensin II and inactivating bradykinin. With more than 30% identity, the AT 1 receptor is one of the closest relatives of the B 2 receptor. In agreement with the high homology, a direct interaction between the angiotensin II AT 1 receptor and the bradykinin B 2 receptor in vivo in rat brain is known since 1993 [1] . We followed those original studies, and identified AT 1 /B 2 receptor heterodimers in different other native systems and in patients with preeclampsia [2, 3] . In addition to the in vivo data, AT 1 /B 2 interactions were also reconstituted in a transfected in vitro system [2, 3] .
Heterodimerization of AT 1 with B 2 receptors leads to signal enhancement of AT 1 [2, 3] . Signal enhancement as a consequence of heterodimerization with the B 2 receptor is also effective for the closely related angiotensin II AT 2 receptor [4] . Both studies were performed with native cells [3, 4] . Thus, a native, correctly folded B 2 receptor protein seems to be required for receptor heterodimerization and signal enhancement.
For various G-protein-coupled receptors, conditions of efficient protein folding were investigated. Different chaperones are known to be involved in the correct folding of AT 1 receptors such as BiP, calnexin, and D 1 RiP78 [5] . By contrast, little is known about chaperones, which assist the folding of B 2 receptors and AT 1 /B 2 receptor heterodimerization. We therefore analyzed requirements for efficient B 2 receptor maturation and the potential interrelationship between B 2 receptor maturation and heterodimerization with the angiotensin II AT 1 receptor.
Materials and methods
Cell culture and cell transfection. HEK293 cells cells were routinely grown in DMEM (100 mg/dl glucose) supplemented with 10 % (v/v) FCS unless otherwise indicated. Cells were transfected with Lipofectamine Plus (Invitrogen). Transfection efficiency of HEK293 cells was ≥90 %. Plasmids encoding the human B 2 and AT 1 receptor under control of the CMV promoter were used. Cellular inositol phosphate levels were determined similarly as described [2] . For down-regulation of calreticulin expression, HEK293 cells were transfected with stealth RNAi (20 pmol/ml) targeting the coding sequence of the human calreticulin cDNA (nucleotides 59-83, RNAi-Calreticulin1 and nucleotides 367-391, RNAiCalreticulin2). Quantification of B 2 receptors was performed on HEK cells with 50 nM of [
125 I]-labeled F(ab) 2 fragments of affinity-purified B 2 receptor-specific antibodies (~1 µCi) similarly as described [6] . Protein detection in immunoblot and co-enrichment of receptors. Protein detection in immunoblot was performed with membranes prepared by sucrose density gradient centrifugation followed by partial enrichment as described [2] . For co-enrichment of AT 1 and B 2 receptors, membranes of HEK cells were solubilized with RIPA buffer (including protease inhibitor cocktail) and subjected to immuno-affinity chromatography by anti-AT 1 receptor antibodies using 0.1 ml immunoaffinity matrix (Affigel 10; 15 mg affinity-purified antibodies per ml gel). After extensive washing, proteins were eluted with 0.2 M glycine, pH 2.5, neutralized, desalted, delipidated and precipitated [2] . Eluted proteins were dissolved and separated by urea-containing SDS-PAGE under reducing conditions. Enriched AT 1 and coenriched B 2 receptors were identified in immunoblot with F(ab) 2 fragments of the respective anti-receptor antibodies. Enrichment of the B 2 receptor was performed analogously with anti-B 2 receptor antibodies. Chemical deglycosylation of the enriched B 2 receptor was performed with trifluoromethanesulfonic acid (TFMS) at 0 °C as described [7] .
Cross-linking of bradykinin to the B 2 receptor. Cross-linking of bradykinin (5 nM) to the B 2 receptor was performed with 0.2 mM m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) in the absence or presence of a 400-fold molar excess of the B 2 -specific antagonist HOE140 at 4 °C using membranes prepared from B 2 receptor-expressing HEK293 cells as described previously [2, 8] . Solubilized proteins were separated by SDS-PAGE under reducing conditions including 6 M urea followed by immunoblotting with anti-bradykinin antibodies [2] .
Antibodies used for immunoblotting and immunofluorescence. All antibodies used for immunoblotting, receptor immunoaffinity enrichment and immunofluorescence were characterized in previous studies [2, 3, 6, [8] [9] [10] . Immunofluorescence was performed with paraformaldehyde-fixed (4 % w/v) cells [6] .
Microarray gene expression profiling. For microarray gene expression analysis, HEK293 cells were cultivated for 7 days in DMEM supplemented with 10 % FCS and 100 mg/dl (low) or 450 mg/dl (high) glucose. Total RNA was isolated with the RNeasy Mini kit (Qiagen). Procedures for cDNA synthesis, labeling and hybridization were carried out according to the protocol of the manufacturer (Affymetrix GeneChip Expression Analysis Technical Manual; Rev. 5). For hybridization, 15 µg of fragmented cRNA were incubated with the chip (Affymetrix GeneChip Human genome U133 Plus 2.0 Array) in 200 µl of hybridization solution in a Hybridization Oven 640 (Affymetrix) at 45 °C for 16 h. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450. Microarrays were scanned with the Affymetrix GeneChip Scanner 7G, and the signals were processed using GCOS (v. 1.4, Affymetrix). Gene expression data are available at GEO accession no GSE15575.
Statistics. Unless otherwise stated, data are expressed as mean ± S.E. To determine significance between two groups, we made comparisons using the unpaired two-tailed Student`s t-test. P values of < 0.05 were considered significant.
Results

Transfected HEK293 cells synthesize a monomeric B 2 receptor that resembles the native B 2 receptor protein
Protein maturation was assessed with HEK293 cells as an expression system because the B 2 receptor protein of transfected HEK293 cells appeared as a pure monomer (Fig. 1A) . Even at high receptor expression levels (>5 pmol/mg protein), the B 2 receptor expressed in HEK293 cells did not show significant protein aggregation under reducing conditions of SDS-PAGE supplemented with urea (Fig. 1A) . The B 2 receptor protein of transfected HEK293 cells showed a similar apparent molecular mass in SDS-PAGE as the native B 2 receptor protein of various native tissues and cells (Fig. 1B) . Detection of the B 2 receptor by immunofluorescence revealed the predominant membrane localization of the transfected B 2 receptor on HEK293 cells (Fig. 1C) . Altogether, these findings indicate that HEK293 cells express all the proteins necessary for efficient B 2 receptor folding.
High glucose induces an immature B 2 receptor protein in HEK293 cells
Expression of mature and correctly folded receptors on the plasma membrane depends on the general chaperone system of the endoplasmic reticulum (ER) controlling protein synthesis, folding and assembly [11] . To assess the impact of the general chaperone system on B 2 receptor folding and AT 1 /B 2 receptor heterodimerization, we down-regulated the general chaperone system of HEK293 cells by high glucose [12] . Cultivation of HEK293 cells in a standard medium with high glucose (450 mg/dl) led to the appearance of an "immature" B 2 receptor-reactive band of ~53 ± 4 kDa in addition to the (mature) B 2 receptor of 67 ± 5 kDa (Fig. 2A) .
The B 2 receptor-reactive band of 53 kDa did not show a high-affinity interaction with the agonist bradykinin as assessed by affinity cross-linking (Fig. 2B) . Chemical deglycosylation of the "mature" and "immature" B 2 receptor proteins produced the deglycosylated B 2 receptor of ~ 43 kDa (Fig. 2C) . These experiments strongly suggest that the 53 kDa protein is indeed an immature B 2 receptor which is not fully glycosylated. Interestingly, the immature B 2 receptor of 53 kDa did not interact with the AT 1 receptor as assessed by co-immunoenrichment (Fig. 2D) . Thus, efficient B 2 receptor maturation seems to be required for heterodimerization with the AT 1 receptor.
Microarray gene expression profiling of the general chaperone system of HEK293 cells
To determine chaperone(s) involved in B 2 receptor maturation and AT 1 /B 2 receptor heterodimerization, we performed microarray gene expression profiling of HEK293 cells cultivated in low and high glucose medium, respectively. Differentially expressed proteins of the ER protein quality-control system were identified by selection of probe sets with (i) ≥ 2.5-fold higher expression in low versus high glucose, (ii) ER localization according to gene ontology (GO) analysis, and (iii) involvement in the general chaperone system according to the literature (Fig. 3A) . The approach identified 14 ER-localized members of the protein quality-control system that showed a more than 2.5-fold higher expression signal in cells cultivated in low glucose relative to high glucose (Fig. 3A) . The microarray gene expression data were verified by immunoblotting as exemplified for GRP78 (Fig. 3B) .
The chaperone calreticulin co-localizes with the B 2 receptor
Several of the identified proteins of the general chaperone system are reported to be involved in folding of membrane proteins [5] . Searching for chaperones that are specifically required for the maturation of B 2 receptors, we focused on calreticulin, because gene inactivation studies revealed an interrelationship between calreticulin and functional B 2 receptor protein levels [13] . Immunoblotting confirmed the microarray-based evidence of a significantly higher calreticulin protein expression in HEK293 cells cultivated in low glucose relative to high glucose (Fig. 3B, middle panel) . As a control, actin protein levels of HEK293 cells were not significantly different (Fig. 3B, lower panel) . In agreement with a potential role of calreticulin in B 2 receptor folding and maturation, immunofluorescence revealed the cellular co-localization of the B 2 receptor with calreticulin (Fig. 3C) .
Down-regulation of calreticulin expression by RNA interference impairs B 2 receptor maturation and AT 1 /B 2 receptor heterodimerization
To determine the potential involvement of calreticulin in B 2 receptor maturation, we down-regulated the expression of calreticulin by RNA interference. Upon down-regulation of calreticulin, the maturation of the B 2 receptor protein was significantly affected as evidenced by the appearance of the immature B 2 receptor protein band of 53 kDa even when cells were cultivated in a medium with a physiological (low) glucose concentration (Fig. 4A) .
Moreover, down-regulation of calreticulin strongly reduced the AT 1 /B 2 receptor interaction because only the fully mature B 2 receptor of 67 kDa was capable to interact with AT 1 whereas the immature B 2 receptor of 53 kDa was not significantly co-enriched with AT 1 (Fig. 4B) . Concomitantly, the B 2 receptor-mediated enhancement of the AT 1 -stimulated signal -an additional indicator of AT 1 /B 2 receptor heterodimerization -was strongly decreased upon down-regulation of calreticulin (Fig. 4C ). Together these data suggest that endogenous calreticulin expression levels of HEK293 cells are sufficient to enhance B 2 receptor maturation and AT 1 /B 2 receptor heterodimerization.
Discussion
In various in vivo systems the receptor for the vasodepressor bradykinin, B 2 , undergoes a functional interaction with the receptor for the vasopressor angiotensin II, AT 1 [1] [2] [3] 14] . The covalently bonded AT 1 /B 2 receptor heterodimers are distinguished from individual, dissociable receptors by a kinetically favored interaction with G-proteins leading to enhanced AT 1 -stimulated signaling [2] [3] . Because increased formation of AT 1 /B 2 receptor heterodimers could constitute a pathological feature of hypertensive disorders [3, 14] , the current study investigated mechanisms required for functional AT 1 /B 2 receptor heterodimerization.
Several lines of evidence are presented supporting that efficient protein maturation of the B 2 receptor is a prerequisite for functional interaction with AT 1 . First, only the mature B 2 receptor interacted with co-expressed AT 1 as determined by co-enrichment. Second, microarray gene expression profiling revealed a correlation between efficient AT 1 /B 2 receptor heterodimerization and the expression of the general chaperone system. Finally, RNA interference studies determined the involvement of the chaperone calreticulin in B 2 receptor maturation and AT 1 /B 2 receptor heterodimerization. Future studies will have to assess whether the herein identified requirement of specific chaperone(s) for AT 1 /B 2 receptor heterodimerization is a factor involved in the induction of AT 1 /B 2 receptor heterodimers under pathophysiological conditions. antibodies (268 ± 9 fmol/mg protein of B 2 receptor and 139 ± 8 fmol/mg protein of AT 1 receptor). Data represent mean ± S.E., n=3 (*p < 0.04; **p < 0.002).
